Just In From Dr. Mercola On Dementia/alz

Discussion in 'Health & Wellness' started by Joy Martin, Apr 17, 2022.

  1. Joy Martin

    Joy Martin Veteran Member
    Registered

    Joined:
    May 4, 2019
    Messages:
    4,694
    Likes Received:
    2,764
    https://articles.mercola.com/sites/...1HL&cid=20220417&mid=DM1154019&rid=1464152359

    STORY AT-A-GLANCE
    • Methylene blue helps mitochondrial respiration and improves brain energy metabolism. By doing that, it can improve cognitive performance and prevent neurodegeneration

    • Methylene blue is the parent molecule for hydroxychloroquine and chloroquine, off-patent drugs commonly used to treat not only malaria but also COVID-19

    • Emergency rooms around the world use it, as it’s the only known antidote for metabolic poisons causing methemoglobinemia, which is when a metabolic poison interferes with the transport of oxygen in hemoglobin

    • Methylene blue is a hormetic drug, so low doses have the opposite effect of high doses
    • Low doses, 0.5 mg to 1 mg per kilo of bodyweight, are recommended for nonacute, longer-term treatments. Uses include the prevention and treatment of dementia, post-stroke and other brain injuries, cognitive enhancement, and the general optimization of health if you’re already healthy
     
    #1
  2. John Brunner

    John Brunner Senior Staff
    Staff Member Senior Staff Greeter Task Force Registered

    Joined:
    May 29, 2020
    Messages:
    25,248
    Likes Received:
    37,072
    That's interesting.

    Methylene blue was a cure-all when I had aquarium fish. I had a small sick tank where I I kept the M.B. concentration level high without breaking the bank.

    Since it's cheap, effective, readily available, with years of use behind it, Pfizer will have the Fed ban it and we'll be hearing derisive stories of "Fish Paste" on the news.

    Any idea on how a theoretical person would theoretically measure doses when some products are 1% solution and others are 0.5% solution?
     
    #2
    Last edited: Apr 18, 2022

Share This Page